Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell transplantation for COVID-19 pneumonia
IRCT20200426047206N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3 trial of mesenchymal stem cell therapy (Hexun Biosciences) in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia, sponsored by Hamadan University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
mesenchymal stem cell therapy (Hexun Biosciences)
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20200426047206N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200426047206N2.